A previous study reported an increase in CAV1 expression in the AT of obese individuals, with or without T2DM, and an association between CAV1 and several inflammatory markers, suggesting a prospective role for CAV1 in obesity-related chronic low-grade inflammation, called metabolic inflammation [13]. The gene discussed is CAV1; the disease is obesity due to melanocortin 4 receptor deficiency.